Actively Recruiting
Assessment of the Role of Incisura Biopsy in the Staging of Chronic Gastritis
Led by Clinical Hospital Colentina · Updated on 2026-03-09
400
Participants Needed
2
Research Sites
205 weeks
Total Duration
On this page
Sponsors
C
Clinical Hospital Colentina
Lead Sponsor
I
Instituto Portugues de Oncologia, Francisco Gentil, Porto
Collaborating Sponsor
AI-Summary
What this Trial Is About
This prospective multicenter study investigates the added benefit of incisura biopsy to correct identification of patients with high-risk chronic gastritis (OLGA stages III-IV). It compares a biopsy protocol with and without a single incisura biopsy in a non-inferiority design. Anonymized photo and videodocumentation according to institution practices will constitute a databank for lesion recognition, quality improvement, and potential AI development.
CONDITIONS
Official Title
Assessment of the Role of Incisura Biopsy in the Staging of Chronic Gastritis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Indication to perform upper GI endoscopy for diagnosis or surveillance
You will not qualify if you...
- Lack of informed consent
- Previously diagnosed advanced gastric cancer
- Incomplete endoscopy
- Surgically altered stomach
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
IPO Porto
Porto, Portugal
Actively Recruiting
2
Colentina Clinical Hospital
Bucharest, Bucharest, Romania, 021025
Actively Recruiting
Research Team
A
Andrei Voiosu
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here